TEVA PHARMACEUTICAL INDUSTRIES LIMITED Increase (Decrease) in Other Current Assets
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Increase (Decrease) in Other Current Assets of -$278.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-07-29
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in other current assets for the quarter ending 2026-06-30 was -$278.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in other current assets for the quarter ending 2026-03-31 was -$302.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in other current assets for the quarter ending 2025-06-30 was -$470.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in other current assets for the quarter ending 2025-03-31 was -$275.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in other current assets for fiscal 2025 was -$1.33B.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in other current assets for fiscal 2024 was -$1.10B.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in other current assets for fiscal 2023 was -$1.52B.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in other current assets for fiscal 2022 was -$828.00M.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|
| 2026-06-30 | -$278.00M 10-Q · filed 2026-07-29 | -$578.00M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | -$302.00M 10-Q · filed 2026-04-29 | ||
| 2025-12-31 | -$1.33B 10-K · filed 2026-02-03 | ||
| 2025-06-30 | -$470.00M 10-Q · filed 2026-07-29 | -$746.00M 10-Q · filed 2026-07-29 | |
| 2025-03-31 | -$275.00M 10-Q · filed 2026-04-29 | ||
| 2024-12-31 | -$1.10B 10-K · filed 2026-02-03 | ||
| 2023-12-31 | -$1.52B 10-K · filed 2026-02-03 | ||
| 2022-12-31 | -$828.00M 10-K · filed 2025-02-05 | ||
| 2021-12-31 | -$2.27B 10-K · filed 2024-02-12 | ||
| 2020-12-31 | -$1.47B 10-K · filed 2023-02-10 | ||
| 2019-12-31 | -$1.42B 10-K · filed 2022-02-09 | ||
| 2018-12-31 | -$1.44B 10-K · filed 2021-02-10 | ||
| 2017-12-31 | $658.00M 10-K · filed 2020-02-21 | ||
| 2016-12-31 | -$517.00M 10-K · filed 2019-02-19 | ||
| 2015-12-31 | $87.00M 10-K · filed 2018-02-12 | ||
| 2014-12-31 | -$36.00M 20-F · filed 2017-02-15 | ||
| 2013-12-31 | $106.00M 20-F · filed 2016-02-11 | ||
| 2012-12-31 | -$54.00M 20-F · filed 2015-02-09 | ||
| 2011-12-31 | -$240.00M 20-F · filed 2014-02-10 | ||
| 2010-12-31 | $51.00M 20-F · filed 2013-02-12 | ||
| 2009-12-31 | $137.00M 20-F · filed 2012-02-17 |